Should risperidone (Risperdal) be discontinued in a patient with possible dementia who experiences increased confusion, thought blocking, and forgetfulness after starting the medication?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, Discontinue Risperidone Immediately

You should stop risperidone immediately in this patient with possible dementia who is experiencing increased confusion, thought blocking, and forgetfulness, as these symptoms represent cognitive worsening that contradicts the primary goal of treatment and may indicate adverse drug effects. 1

Critical Safety Considerations

The FDA explicitly warns that risperidone is not approved for treatment of patients with dementia-related psychosis and carries a boxed warning for increased mortality risk in this population. 1 The cognitive symptoms you describe—increased confusion, thought blocking, and forgetfulness—represent exactly the type of harm that outweighs any potential benefit in dementia patients.

Evidence Against Continuing Risperidone

Harm Demonstrated in High-Quality Studies

  • A 2018 randomized controlled trial in palliative care settings found that risperidone was associated with higher delirium symptom severity scores compared to placebo and resulted in poorer overall survival in long-term follow-up. 2

  • The ESMO guidelines explicitly state that administration of either haloperidol or risperidone has no demonstrable benefit in symptomatic management of mild-to-moderate delirium and is not recommended in this context. 2

Cognitive Side Effects Are Well-Documented

  • The cognitive worsening you're observing (confusion, thought blocking, forgetfulness) aligns with known anticholinergic and sedating effects that can worsen dementia symptoms. 1

  • Extrapyramidal symptoms, which can manifest as thought blocking and cognitive slowing, occur in a dose-dependent manner with risperidone, even at low doses in elderly patients. 3, 4

What to Do After Discontinuation

Immediate Actions

  • Stop risperidone immediately without tapering if the patient has only been on it for a short period (days to weeks). 1

  • Monitor for symptom improvement over 48-72 hours; cognitive symptoms from antipsychotic toxicity often improve within this timeframe. 2

Evaluate Underlying Causes

  • Assess for delirium precipitants including infection, metabolic disturbances (hypercalcemia, hypomagnesemia, SIADH), medication effects, or opioid-induced neurotoxicity if applicable. 2

  • Review all medications for anticholinergic burden and other cognitive impairing agents that should be deprescribed. 2

Alternative Management Strategies

If behavioral symptoms require treatment after addressing reversible causes:

  • Non-pharmacological interventions should be first-line, including environmental modifications, reorientation strategies, and caregiver education. 2

  • If pharmacological treatment is absolutely necessary for severe agitation threatening harm, consider:

    • Quetiapine 12.5-25 mg daily (may offer benefit with less cognitive impairment) 2
    • Olanzapine 2.5 mg daily (may offer benefit but monitor metabolic effects) 2
    • These should only be used at the lowest effective dose for the shortest duration possible 3

Common Pitfalls to Avoid

  • Do not increase the risperidone dose in response to worsening symptoms, as this will likely worsen cognitive function further. 5

  • Do not assume behavioral symptoms require antipsychotics; in dementia patients, these medications often cause more harm than benefit. 2

  • Do not restart risperidone even at a lower dose, given the clear temporal relationship between drug initiation and cognitive decline. 1

Documentation and Monitoring

  • Document the temporal relationship between risperidone initiation and symptom onset. 1

  • Monitor for improvement in confusion, thought processes, and memory over the next 3-7 days after discontinuation. 2

  • If symptoms persist after discontinuation, this suggests the underlying dementia or another medical condition rather than drug effect, requiring further evaluation. 2

Related Questions

What are the appropriate oral and intramuscular dosing regimens for lorazepam (benzodiazepine) and risperidone (antipsychotic) in a patient aged 80 years or older with behavioral and psychological symptoms of dementia?
What medication should be tried next for an elderly patient with dementia and disruptive behavior who is not responding to Risperdal (risperidone)?
In a 62-year-old male with Down syndrome, anxiety disorder, major depression, and dementia who is in rehabilitation after recent hospitalization for altered mental status and is currently on risperidone 1 mg at bedtime and buspirone (Buspar) 10 mg in the morning and 20 mg at night, but remains restless, confused, and anxious with frequent yelling despite a one‑to‑one sitter, what management steps should be taken?
In an elderly patient with significant sundowning who is receiving 1 milligram of oral risperidone in the evening without adequate control, what is the next best medical step?
What is the recommended interval between doses for medications like risperidone or quetiapine when administered three times a day for behavioral issues and dementia?
What is the protocol for assessing and managing troponin levels in patients with suspected acute coronary syndrome?
Is erythromycin (macrolide antibiotic) safe to use during pregnancy?
What psych medications are effective for a geriatric Chronic Obstructive Pulmonary Disease (COPD) patient with anxiety exacerbated by shortness of breath?
What is the appropriate dosage of Actrapid (human insulin) based on capillary blood glucose (CBG) levels?
What causes numb fingertips?
What is the infusion duration for intravenous (IV) acetazolamide?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.